What clinicians must know about diabetic dyslipidemia

Professor Martin Clodi shares his insights what clinicians must know about diabetic dyslipidemia at the 4th World Congress of Lipidology in Vienna, Austria.

How to treat elevated Lp(a)

Professor Karam Kostner shares his insights how to treat elevated Lp(a) at the 4th World Congress of Lipidology in Vienna, Austria?

The lower the better: never mind future drugs, use what you have available to fullest extent and lower cardiovascular risk aggressively

Professor Peter Toth shares his insights on how to lower cardiovascular risk at the 4th World Congress of Lipidology in Vienna, Austria.

How to treat elevated TG in other high risk patients

Professor Thomas Stulnig shares his insights on how to treat elevated TG in other high risk patients at the 4th World Congress of Lipidology in Vienna, Austria.

What will change in the lipid lowering landscape in the next 5 years?

Professor Maciej Banach shares his insights what will change in the lipid lowering landscape in the next 5 years at the 4th World Congress of Lipidology in Vienna, Austria.

Newborn Screening for Atherosclerosis Risk?

Professor Caroline Bachmeier shares her insights on the rationale of small children and newborn screening for atherosclerosis at the 4th World Congress of Lipidology in Vienna, Austria.

How to implement LDL guidelines?

Professor Gerald Watts shares his insights how to implement LDL guidelines at the 4th World Congress of Lipidology in Vienna, Austria.

LDL lowering in 2025: Optimal approach

Professor Dereck Connolly shares his insights on LDL lowering in 2025 at the 4th World Congress of Lipidology in Vienna, Austria.

Diabetic Dyslipidemia: Beyond LDL – Atherogenic Lipoproteins in Focus

Professor Gersina Rega Kaun shares her insights on lipid lowering in diabetics at the 4th World Congress of Lipidology in Vienna, Austria.